These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15595575)

  • 1. Temperature/Humidity sensitivity of sustained-release formulations containing Kollidon SR.
    Engineer S; Shao ZJ; Khagani NA
    Drug Dev Ind Pharm; 2004; 30(10):1089-94. PubMed ID: 15595575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
    Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
    Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tableting and tablet properties of Kollidon SR: the influence of moisture and mixtures with theophylline monohydrate.
    Hauschild K; Picker-Freyer KM
    Pharm Dev Technol; 2006 Feb; 11(1):125-40. PubMed ID: 16544916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of formulation variables and post-compression curing on drug release from a new sustained-release matrix material: polyvinylacetate-povidone.
    Shao ZJ; Farooqi MI; Diaz S; Krishna AK; Muhammad NA
    Pharm Dev Technol; 2001; 6(2):247-54. PubMed ID: 11416999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the aqueous film coating process on the properties and stability of tablets containing a moisture-labile drug.
    Ruotsalainen M; Heinämäki J; Taipale K; Yliruusi J
    Pharm Dev Technol; 2003; 8(4):443-51. PubMed ID: 14601968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study between conventional pan coater and quasi-continuous small batch coater on the stability of tablets containing acetylsalicylic acid.
    Cahyadi C; Chan LW; Heng PW
    Eur J Pharm Biopharm; 2015 Feb; 90():30-7. PubMed ID: 25448074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
    Li XN; Guo HX; Heinamaki J
    J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of relative humidity during coating on polymer deposition and film formation.
    Macchi E; Felton LA
    Int J Pharm; 2016 Aug; 510(1):116-24. PubMed ID: 27282533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
    Tantry JS; Tank J; Suryanarayanan R
    J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPTIMIZATION OF THE PREPARATION OF KOLLIDON SR-BASED AMIODARONE HYDROCHLORIDE TABLETS WITH SUSTAINED RELEASE.
    Creţeanu A; Tàntaru G; Vieriu M; Panainte AD; Ochiuz L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1161-5. PubMed ID: 26793864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of moisture sorption on the performance of crospovidone.
    Hiew TN; Johan NAB; Desai PM; Chua SM; Loh ZH; Heng PWS
    Int J Pharm; 2016 Nov; 514(1):322-331. PubMed ID: 27863679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
    Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
    Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into moisture barrier film coating efficacy and its relevance to drug stability in solid dosage forms.
    Mwesigwa E; Basit AW
    Int J Pharm; 2016 Jan; 497(1-2):70-7. PubMed ID: 26551674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.